No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Cleviprex (clevidipine) is a calcium channel blocker used to treat hypertension and other cardiovascular conditions. It is a short-acting, intravenous antihypertensive agent that works by selectively blocking calcium channels in the smooth muscle cells of the arterial wall, resulting in a decrease in peripheral vascular resistance and a decrease in blood pressure. Cleviprex is approved for use in adults and children over the age of two.
Cleviprex is a part of the larger cardiovascular drug market, which includes a variety of medications used to treat conditions such as hypertension, coronary artery disease, and congestive heart failure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The Cleviprex market is comprised of several companies, including Fresenius Kabi, Pfizer, and Merck. Other companies in the market include Novartis, Sanofi, and AstraZeneca. Show Less Read more
